Statistics
Publications
12
Citations
2.3K
H-Index
11
Active since
2008
Kimberly M. Komatsubara is an author at Columbia University Irving Medical Center specializing in oncology, medicine, and molecular oncology.
Publications per year
2008–2024
12
12
Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC
Roy S. Herbst, Giuseppe Giaccone, Filippo de Marinis et al. · New England Journal of Medicine · 2020 · 1.7K citations · Full text
Medicine, Oncology, Pharmacology +17
Jacek Jassem, Filippo de Marinis, Giuseppe Giaccone et al. · Journal of Thoracic Oncology · 2021 · 202 citations
Medicine, Oncology, Pharmacology +13
Clinical Management of Uveal and Conjunctival Melanoma.
Elyse S. Blum, Jessica Yang, Kimberly M. Komatsubara et al. · PubMed · 2016 · 76 citations
Medicine, Oncology, Ophthalmology +17
Hepatotoxin-Induced Changes in the Adult Murine Liver Promote MYC-Induced Tumorigenesis
Shelly Beer, Kimberly M. Komatsubara, David I. Bellovin et al. · PLoS ONE · 2008 · 46 citations · Full text
Medicine, Oncology, Toxicology +17
Low-level shRNA Cytotoxicity Can Contribute to MYC-induced Hepatocellular Carcinoma in Adult Mice
Shelly Beer, David I. Bellovin, Joyce Lee et al. · Molecular Therapy · 2009 · 45 citations · Full text
Medicine, Oncology, Toxicology +17
1–5 of 12